查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1414470

2024 年类器官全球市场报告

Organoids Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，类器官的市场规模迅速扩大。将从2023年的14.2亿美元扩大到2024年的17.8亿美元，复合年增长率为25.1%。这段时期的扩张是由于生物医学研究的进步、药物研发发现研发需求的不断变化、疾病建模的需求、个人化医疗的日益普及以及支持性的法规环境。

类器官市场规模预计在未来几年将大幅成长。 2028年，将以25.2%的复合年增长率成长至43.8亿美元。预测期内的增长可能是由于慢性病发病率迅速上升、基因组编辑技术的进步、干细胞研究活性化、合资企业和合作伙伴关係以及对临床应用的日益关注。

慢性病和感染疾病的预期成长预计将推动类器官市场的成长。用于研究这些疾病和治疗方法的类器官为病原体生物学和药物筛检提供了快速、可靠的见解。截至2023年1月，美国生物技术资讯中心估计，美国50岁及以上患有慢性病的人数将从2020年的71,522,000人增加到2050年的142,660,000人，预计增加近99.5%。

越来越多的针对药物开发的临床试验正在推动类器官市场的扩张。截至2023年5月17日，全球整体在ClinicalTrials.gov註册的此类临床试验共有452,604项，高于2021年初的365,000多项，显示类器官的使用正在扩大。类器官用于疾病建模和完善个人化医疗，在促进科学理解和改善患者照护方面发挥着至关重要的作用，巩固了它们对市场成长的贡献。

到 2023 年，北美将成为类器官市场最大的地区。预计亚太地区将成为预测期内成长最快的地区。类器官市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美以及中东和非洲。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与抑制因素
    • 市场驱动因素
    • 市场抑制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章市场区隔

  • 全球类器官市场，依产品细分、实际及预测，2018-2023、2023-2028、2033
  • 肝臟类器官
  • 大肠直肠类器官
  • 肠类器官
  • 其他类器官
  • 全球类器官市场，依来源、实际及预测细分，2018-2023、2023-2028、2033
  • 多功能细胞
  • 器官特异性成体干细胞
  • 全球类器官市场，依应用细分、实际状况及预测，2018-2023、2023-2028、2033
  • 发育生物学
  • 感染疾病的疾病病理学
  • 再生医学
  • 测试药物毒性和功效
  • 药物研发与个人化医疗
  • 其他用途
  • 全球类器官市场，按最终用户细分，实际和预测，2018-2023、2023-2028、2033
  • 医院和诊断中心
  • 生物技术和製药公司
  • 其他最终用户

第 7 章 区域与国家分析

  • 全球类器官市场，按地区、实际和预测，2018-2023、2023-2028、2033
  • 全球类器官市场，依国家、实际及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 类器官市场竞争形势
  • 类器官市场公司简介
    • Cellesce Ltd.
    • STEMCELL Technologies
    • HUB Organoids
    • DefiniGEN
    • 3Dnamics Inc.

第31章竞争基准化分析

第 32 章竞争对手仪表板

第三十三章 重大併购

第34章 未来前景与可能性分析

第35章附录

简介目录
Product Code: r11980

“Organoids Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on organoids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for organoids? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The organoids market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product: Hepatic Organoid; Colorectal Organoid; Intestinal Organoid; Other Organoid
  • 2) By Source: Pluripotent Stem Cells; Organ-Specific Adult Stem Cells
  • 3) By Application: Developmental Biology; Disease Pathology Of Infectious Disease; Regenerative Medicine; Drug Toxicity And Efficacy Testing; Drug Discovery And Personalized Medicine; Other Applications
  • 4) By End-User: Hospitals And Diagnostic Centers; Biotechnology And Pharmaceutical Companies; Other End-Users
  • Companies Mentioned: Cellesce Ltd.; STEMCELL Technologies; HUB Organoids; DefiniGEN; 3Dnamics Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Organoids, intricate three-dimensional tissue cultures derived from stem cells, serve as invaluable assets in tailored regenerative medicine, gene repair, and transplantation therapy.

These organoids come in various forms such as hepatic, colorectal, and intestinal, among others. Hepatic organoids, for instance, represent fully functional in vitro models of the liver. They play a pivotal role in addressing an array of research queries related to hepatic development, regeneration, and disease modeling.

These groundbreaking tools harness different sources, including pluripotent stem cells and organ-specific adult stem cells. They find application across developmental biology, infectious disease pathology, regenerative medicine, drug efficacy and toxicity testing, as well as drug discovery and personalized medicine.

Their adoption spans a wide spectrum, encompassing hospitals, diagnostic centers, biotechnology and pharmaceutical companies, and other industries seeking to leverage their immense potential for advancements in healthcare and research.

The organoids market research report is one of a series of new reports from The Business Research Company that provides organoids market statistics, including organoids industry global market size, regional shares, competitors with a organoids market share, detailed organoids market segments, market trends, and opportunities, and any further data you may need to thrive in the organoids industry. This organoids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The organoids market size has grown exponentially in recent years. It will grow from $1.42 billion in 2023 to $1.78 billion in 2024 at a compound annual growth rate (CAGR) of 25.1%. The expansion observed during the historical period can be credited to progress in biomedical research, the evolving demands of drug discovery and development, the necessity for disease modeling, the rising popularity of personalized medicine, and the supportive regulatory environment.

The organoids market size is expected to see exponential growth in the next few years. It will grow to $4.38 billion in 2028 at a compound annual growth rate (CAGR) of 25.2%. Anticipated growth in the forecast period is likely due to a surge in chronic disease rates, advancements in genome editing techniques, an upswing in stem cell research, collaborative ventures and partnerships, and intensified efforts in clinical translation.

The anticipated rise in chronic and infectious diseases is projected to drive growth in the organoid market. Organoids, used for studying these diseases and treatments, offer rapid and reliable insights into pathogen biology and drug screening. As of January 2023, the National Center for Biotechnology Information forecasts a nearly 99.5% increase in the U.S. population over 50 with chronic diseases, from 71.522 million in 2020 to an estimated 142.66 million by 2050, affirming the market's growth trajectory due to heightened chronic disease prevalence.

The escalating number of clinical trials aimed at drug development is set to fuel the expansion of the organoid market. These trials, totaling 452,604 globally as of May 17, 2023, registered on ClinicalTrials.gov-an increase from over 365,000 trials in early 2021, underscore the growing utilization of organoids. Leveraged in modeling diseases and refining personalized medicine, organoids play a pivotal role in advancing scientific understanding and improving patient care, solidifying their contribution to market growth.

Technological advancements stand as a prominent trend shaping the organoid market. Companies within this sector continuously introduce cutting-edge technologies to fortify their market positions. Notably, in March 2023, MIMETAS unveiled the OrganoReady product line featuring a novel adult stem cell-derived tubular organoid, harnessing innovative technology for mechanistic toxicology and drug-induced organ injury assessments. Developed on the patented microfluidic platform, OrganoPlate, these perfused 3D structures demonstrate the industry's commitment to pioneering advancements in organoid technologies.

Market leaders prioritize the development of pioneering platforms such as organoid panel screening, driving progress in preclinical oncology drug discovery. For example, in November 2023, Crown Bioscience launched OrganoidXplore, a revolutionary large-scale organoid panel screening platform. Utilizing their AR organoid technology, this platform streamlines preclinical drug discovery by offering reliable drug response comparisons that faithfully replicate original tumors' genomic, morphological, and pathophysiological characteristics. With enhanced performance and cost-effectiveness, OrganoidXplore signals a significant stride in accelerating oncology drug discovery.

In December 2022, Molecular Devices LLC, a UK-based research and development company, acquired Cellesce Ltd. for an undisclosed amount. The acquisition will provide Molecular Devices LLC with Cellesce Ltd human-derived cell or organoid lines and strengthen the company's position as a 3D biology solutions innovator. Cellesce Ltd is a UK-based company with expertise in cell expansion focused on organoids.

Major companies operating in the organoids market report are Cellesce Ltd., STEMCELL Technologies, HUB Organoids, DefiniGEN, 3Dnamics Inc., OcellO B.V., Organoid Therapeutics, PeproTech Inc., QGel SA, Corning Incorporated, Thermo Fisher Scientific, Trevigen Inc., Path BioAnalytics, R&D Systems, Merck KGaA, 3D BioMatrix Inc., 3D Biotek LLC, AMS Biotechnology (Europe) Limited, Greiner Bio-One, 3-D Matrix, InSphero AG, Synthego Corporation, Axol Bioscience Ltd., TissUse GmbH, CytoSMART Technologies BV, EMD Millipore Corporation, Epithelix Sarl

North America was the largest region in the organoids market in 2023. Asia-pacific is expected to be the fastest-growing region in the global organoids market size forecast period. The regions covered in the organoids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the organoids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The organoids market consists of sales of epithelial organoid, embryonic organoid, and cerebral organoid. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Organoids Market Characteristics

3. Organoids Market Trends And Strategies

4. Organoids Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Organoids Market Size and Growth

  • 5.1. Global Organoids Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Organoids Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Organoids Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Organoids Market Segmentation

  • 6.1. Global Organoids Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hepatic Organoid
  • Colorectal Organoid
  • Intestinal Organoid
  • Other Organoid
  • 6.2. Global Organoids Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pluripotent Stem Cells
  • Organ-Specific Adult Stem Cells
  • 6.3. Global Organoids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Developmental Biology
  • Disease Pathology Of Infectious Disease
  • Regenerative Medicine
  • Drug Toxicity And Efficacy Testing
  • Drug Discovery And Personalized Medicine
  • Other Applications
  • 6.4. Global Organoids Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Diagnostic Centers
  • Biotechnology And Pharmaceutical Companies
  • Other End-Users

7. Organoids Market Regional And Country Analysis

  • 7.1. Global Organoids Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Organoids Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Organoids Market

  • 8.1. Asia-Pacific Organoids Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Organoids Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Organoids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Organoids Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Organoids Market

  • 9.1. China Organoids Market Overview
  • 9.2. China Organoids Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Organoids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Organoids Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Organoids Market

  • 10.1. India Organoids Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Organoids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Organoids Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Organoids Market

  • 11.1. Japan Organoids Market Overview
  • 11.2. Japan Organoids Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Organoids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Organoids Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Organoids Market

  • 12.1. Australia Organoids Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Organoids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Organoids Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Organoids Market

  • 13.1. Indonesia Organoids Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Organoids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Organoids Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Organoids Market

  • 14.1. South Korea Organoids Market Overview
  • 14.2. South Korea Organoids Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Organoids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Organoids Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Organoids Market

  • 15.1. Western Europe Organoids Market Overview
  • 15.2. Western Europe Organoids Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Organoids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Organoids Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Organoids Market

  • 16.1. UK Organoids Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Organoids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Organoids Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Organoids Market

  • 17.1. Germany Organoids Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Organoids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Organoids Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Organoids Market

  • 18.1. France Organoids Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Organoids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Organoids Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Organoids Market

  • 19.1. Italy Organoids Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Organoids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Organoids Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Organoids Market

  • 20.1. Spain Organoids Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Organoids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Organoids Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Organoids Market

  • 21.1. Eastern Europe Organoids Market Overview
  • 21.2. Eastern Europe Organoids Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Organoids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Organoids Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Organoids Market

  • 22.1. Russia Organoids Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Organoids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Organoids Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Organoids Market

  • 23.1. North America Organoids Market Overview
  • 23.2. North America Organoids Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Organoids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Organoids Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Organoids Market

  • 24.1. USA Organoids Market Overview
  • 24.2. USA Organoids Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Organoids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Organoids Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Organoids Market

  • 25.1. Canada Organoids Market Overview
  • 25.2. Canada Organoids Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Organoids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Organoids Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Organoids Market

  • 26.1. South America Organoids Market Overview
  • 26.2. South America Organoids Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Organoids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Organoids Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Organoids Market

  • 27.1. Brazil Organoids Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Organoids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Organoids Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Organoids Market

  • 28.1. Middle East Organoids Market Overview
  • 28.2. Middle East Organoids Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Organoids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Organoids Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Organoids Market

  • 29.1. Africa Organoids Market Overview
  • 29.2. Africa Organoids Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Organoids Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Organoids Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Organoids Market Competitive Landscape And Company Profiles

  • 30.1. Organoids Market Competitive Landscape
  • 30.2. Organoids Market Company Profiles
    • 30.2.1. Cellesce Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. STEMCELL Technologies
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. HUB Organoids
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. DefiniGEN
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. 3Dnamics Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Organoids Market Competitive Benchmarking

32. Global Organoids Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Organoids Market

34. Organoids Market Future Outlook and Potential Analysis

  • 34.1 Organoids Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Organoids Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Organoids Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer